Atlas Trials

Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

Clinical trial NCT06712030 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06712030
Sponsor
Puerta de Hierro University Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Start date
2025-01-01
Primary completion
2027-04-01
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.